Harbour BioMed announced the appointment of Dr. Yingying Chen as Chief Financial Officer (CFO). Dr. Chen will be responsible for leading the overall management of Finance & Investor Relations and overseeing all aspects of financial operations. She will provide leadership and management for company financial planning, business strategy, financing management, cash management, internal control, budgeting, and investor relations. She is expected to manage HBM's Finance and business activities and develop and maintain relationships with existing and potential investors. Dr. Chen joins HBM with more than 20 years of extensive experience, exceptional achievement in the financial and healthcare industries. Before joining HBM, she severed as Managing Director, Head of Healthcare at GF Investments Hong Kong Limited and CMBC International Holdings Ltd.